From May 11, 2023 to June 30, 2023, the company has repurchased 5,669,900 shares, representing 1.51% for ¥7,036.46 million. With this, the company has completed the repurchase of 5,669,900 shares, representing 1.51% for ¥7,036.46 million under the buyback announced on May 11, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,612 JPY | -2.15% | +5.46% | +14.77% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.77% | 383.97Cr | |
+29.71% | 68TCr | |
+30.35% | 59TCr | |
-3.69% | 36TCr | |
+17.74% | 33TCr | |
+3.25% | 28TCr | |
+15.53% | 24TCr | |
+10.16% | 21TCr | |
-8.14% | 20TCr | |
+7.46% | 17TCr |
- Stock Market
- Equities
- 4536 Stock
- News Santen Pharmaceutical Co., Ltd.
- Tranche Update on Santen Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 11, 2023.